[Photo via tuchong.com]
For the global healthcare industry, the International Health Industry Forum of Boao Forum for Asia (BFA) on April 20 can be considered a high-level industrial event.
The forum set up eight sub-forums to interpret and discuss health policies related to industrial trends, regulatory rules, precision surgical development trends and the management of the clinical use of antibiotics in primary medical institutions, and pharmaceutical evaluation points for CGT products.
On the sub-forum "Innovation and Development of Traditional Medicine", expert representatives delivered keynote speeches on topics such as "The Development of Integrated Traditional Chinese and Western Medicine and Future New Medicine," "Reflection and Exploration on the Inheritance and Innovation of Chinese Medicine."
In the roundtable discussion that followed, experts also discussed the theme of "Promoting the Construction of a Healthy China with Innovative Chinese Medicine."
The BFA Global Health Forum, in conjunction with industrial brain HSMAP, released a report on China's traditional Chinese medicine industry innovation" and announced the top 30 innovative enterprises list.
Director of the World Health Organization's Polio Eradication project, Aidan O'Leary, Deputy Dean of the International Trade and Economic Cooperation Research Institute of the Ministry of Commerce Yu Zirong, and other experts exchanged ideas on the spread, symptoms, treatment of poliomyelitis.
At the sub-forum "Actively Addressing the Challenge of Challenge of Antimicrobial Resistance," heads of health departments, representatives from international organizations such as the WHO, scientific research and clinical testing experts, and representatives from leading antimicrobial resistance diagnostic companies gathered to explore how to use innovative technology to guide clinical use of antimicrobials in a simple, accurate, and effective way.
They also discussed ways to improve technical capabilities of clinical use of antimicrobials in county-level and primary medical institutions, promoting the application of clinical bacterial testing, realizing evidence-based standardized use of antimicrobials, and new ways to develop antimicrobial drugs using synthetic biology and other technologies.
